General Methods. All non-hydrolytic reactions were carried out in oven-dried glassware under an inert atmosphere of dry argon or nitrogen. All commercial chemicals were used as received except for solvents, which were purified and dried by standard methods prior to use. Analytical TLC was performed on a Merck 60 F254 silica gel plate (0.25mm thickness), analytical reversephase TLC on a Merck RP-8 F254s, and visualization was done with UV light (254nm and 365nm), or by spraying with a 5% solution of phosphomolybdic acid or ninhydrin solution followed by charring with a heat gun. Column chromatography was performed on Merck 60 silica gel (70-230 or 230-400 mesh), and MPLC was performed on Fluka 100 C 8 -reversed phase silica gel. NMR spectra were recorded on a Bruker DPX 300 ( 1 H-NMR at 300MHz; 13 C-NMR at 75 MHz) and Bruker DRX 500 ( 1 H-NMR at 500MHz; 13 C-NMR at 125MHz) spectrometers.
2,2,2-Trifluoroethyl 3-bromopropionate (1):
To a solution of 2,2,2-trifluoroethanol (15 mL, 208 mmol) in CH 2 Cl 2 (30mL) at 0°C, were added triethylamine (4.5 mL, 32 mmol) and 3-bromopropionyl chloride (2.94 mL, 29 mmol). The mixture was stirred at rt for 5 h. The reaction was quenched with water. The standard extractive workup with EtOAc gave the crude product of which an impurity was precipitated by addition of hexane followed by filtration to give 1 (3.53g, 52 %) as yellow liquid. R f 0.6 (n-Hex : CH 2 Cl 2 = 1:2, twice); 1 H-NMR (CDCl 3 ): δ 3.05 (t, J = 6.7Hz, 2H, CH 2 Br), 3.60 (t, J =6.7Hz, 2H, COCH 2 ), 4.54 (q, J =8.4Hz, 2H, CH 2 CF 3 ) ppm;
13 C-NMR(CDCl 3 ) δ 20. 89, 25.23, 37.20, 60.41, 169.20 
2,2,2-Trifluoroethyl 3-azidopropionate (2):
To a solution of 1 (3.71 g, 15.8 mmol) in dimethylform amide (DMF, 15 mL), were added sodium azide (2.72 g, 63.2 mmol) and tetrabutylammonium iodide (TBAI, 0.69 g, 3.2 mmol). The mixture was stirred at rt for 12 h.
The reaction was quenched with water. The standard extractive workup with EtOAc gave the crude product of which an impurity was precipitated by addition of hexane followed by filtration to give 2 (2.76g, 89 %) as yellow liquid. R f 0.3 (EtOAc: n-Hex = 1: δ 33. 64, 46.89, 61.18, 62.18, 63.28, 70.35, 72.00, 73.42, 73.56, 73.92, 77.83, 82.76, 93.11, 102.89, 171.18 ppm; HRMS (FAB) 88, 26.55, 28.82, 30.11, 31.80, 34.01, 36.87, 40.83, 46.91, 60.75, 61.79, 63.66, 64.00, 68.10, 69.03, 69.91, 70.38, 74.63, 75.48, 79.39, 170.45, 172.31, 172.66, 172.86, 172.90, 173.43, 173.59 97, 25.16, 28.82, 29.34, 30.40, 34.06, 41.08, 46.94, 61.78, 63.84, 68.12, 69.04, 69.84, 70.41, 74.60, 75.54, 79.38, 90.12, 103.82, 156.42, 170.33, 172.40, 172.80, 172.89, 173.05, 173.53, 173.70 A representative procedure for the N-Boc-deprotection: To the HCl (gas) saturated solution of EtOAc (5 mL) at rt, was added 4 (134 mg, 0.069 mmol), and the solution was stirred for 3 h.
The precipitate was separated and dried under vacuum to give the white hydrochloride salt 6
(101 mg, quant.). 44, 26.03, 27.26, 33.51, 33.63, 33.72, 33.85, 33.91, 39.78, 47.09,51.26, 62.01, 63.78, 63.90, 68.36, 69.09, 70.05, 70.57, 74.75, 75.95, 79.22, 90.09, 103.80, 171.08, 172.56, 172.64, 172.89, 172.69, 172.89, 173.02, 173.21, 173.68, 173.76, 174.73 A representative procedure for guanidinylation: To a solution of 6 (101 mg, 0.068 mmol) in a mixed solvent (1,4-dioxane:water=5:1, 5 mL), were added Et 3 N (0.30 mL, 2.037 mmol) and N,N′-di-Boc-N″-trifluoromethanesulfonylguanidine (532 mg, 1.358 mmol), and the reaction mixture was stirred at rt for 3 days. The mixture was diluted with EtOAc, and washed with 1N-NaHSO 4 , saturated NaHCO 3 and brine. The organic layer was separated, dried and concentrated to give the crude product, which was purified by column chromatography on silica gel to afford 8 (133 mg, 67 %) as a white foamy solid. 54, 21.38, 24.67, 26.65, 26.72, 28.41, 28.64, 29.10, 30.01, 33.92, 34.02, 34.07, 34.28, 41.04, 46.88, 60.72, 61.61, 63.57, 64.16, 67.98, 69.02, 69.82, 70.41, 74.79, 75.43, 79.51, 83.31, 90.13, 103.90, 153.60, 156.44, 170.33, 171.46, 172.18, 172.56, 172.66, 172.80, Supplementary Material (ESI) A representative procedure for reduction of the terminal azide moiety: A mixture of 8 (128 mg, 0.044 mmol) and 10 wt.% Pd/C (250 mg) in abs. EtOH was hydrogenated by using a hydrogenator apparatus (50 psi). After stirring for 3 h at rt, the catalyst was filtered and the filtrate was evaporated to give the crude product 10 (102 mg, 80 %) as a white foamy solid. 
1'-O-(3-Aminopropionyl)-2,3,3',4,4',6,6'-hepta-O-[N,N'-bis-Boc-N''-

1'-O-(3-(N-fluoresceinyl-5-thioureido)-propionyl)-
ll. Bioassays
Cell Culture. RAW264.7 cells were cultivated according to a literature procedure. Protocols for the mouse tissue distribution study were previously described.
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